• 페이스북 공유
  • 트위터 공유
  • 미투데이 공유
  • URL복사
  • 더보기
  • 관심의료진 등록

최윤지

  • 진료과

    종양혈액내과

  • 전문진료분야

    폐암, 비뇨기암, 두경부암, 육종, 희귀암

  • 담당클리닉

최윤지

최윤지 교수의 진료시간표 진료예약

진료과/센터 전문진료과목
종양혈액내과 -
오후
종일
-
오전
- 폐암 , 비뇨기암 , 두경부암 , 육종 , 희귀암
암센터 -
오후
종일
-
오전
- 폐암 , 비뇨기암 , 두경부암 , 육종 , 희귀암 , 유전성암 유전상담 (화 오후: 정밀의학클리닉)

최윤지 교수의 상세정보

학력

more
  • 2000 .03  ~  2006 .02  :  고려대학교 의과대학 학사
  • 2008 .09  ~  2010 .08  :  고려대학교 의과대학 석사
  • 2010 .09  ~  2015 .02  :  고려대학교 의과대학 박사

경력

more
  • 2006 .03  ~  2007 .02  :  고려대학교 의료원 인턴
  • 2007 .03  ~  2011 .02  :  고려대학교 의료원 내과 전공의
  • 2011 .03  ~  2012 .02  :  고려대학교 안암병원 종양혈액내과 임상강사
  • 2012 .03  ~  2013 .02  :  서울아산병원 종양내과 임상강사
  • 2013 .03  ~  2016 .08  :  고려대학교 안암병원 종양혈액내과 임상강사, 임상조교수
  • 2016 .09  ~  2020 .02  :  고려대학교 안암병원 종양혈액내과 조교수
  • 2020 .03  ~   :  고려대학교 안암병원 종양혈액내과 부교수

수상내역

more
  • 2011 .06  :  대한항암요법연구회 우수프로토콜상
  • 2013 .11  :  대한종양내과학회 우수연제상
  • 2018 .06  :  대한암학회 우수연제상

학회활동

more
  •  ~   :  미국 암 연구학회 회원
  •  ~   :  대한암학회 정회원
  •  ~   :  대한종양내과학회 정회원
  •  ~   :  대한항암요법연구회 정회원 (비뇨기/부인암 분과 위원, 폐암 분과 위원)
  •  ~   :  대한두경부종양학회 정회원

논문

more
  • [SCI] (The serum bone morphogenetic protein-2 level in non-small-cell lung cancer patients)
  • [SCI] (Werniche’s encephalopathy following allogeneic hematopoietic stem cell transplantation)
  • [SCI] (Small bowel carcinoma in young patient detected by double-balloon enteroscopy)
  • [SCI] (The role of chemotherapy and/or octreotide in patients with metastatic gastroenteropancreatic and hepatobiliary neuroendocrine carcinoma)
  • [SCI] (Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study)
  • [SCI] (Randomized phase II study of paclitaxel/carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapy-naïve non-small cell lung cancer in a clinically selected population excluding patients with non-smoking adenocarcinoma or mutated EGFR)
  • [SCI] (The prognostic role of serum C-X-C chemokine receptor type 4 in patients with metastatic or recurrent colorectal cancer)
  • [SCI] (A case report of primary pericardial malignant mesothelioma treated with pemetrexed and cisplatin)
  • [SCI] (Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05))
  • [SCI] (Association between hand grip strength and impaired health-related quality of life in Korean cancer survivors: a cross-sectional study)
  • [SCI] (A Prognostic index to identify patients with intrahepatic cholangiocarcinoma who could benefit from gemcitabine plus cisplatin)
  • [SCI] (Can serum be used for analyzing the KRAS mutation status in patients with advanced colorectal cancer?)
  • [SCI] (The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progress)
  • [SCI] (Prognostic value of axillary nodal ratio after neoadjuvant chemotherapy of doxorubicin/cyclophosphamide followed by docetaxel: a multicenter retrospective cohort study)
  • [SCI] (Incidence and predictors of febrile neutropenia among early-stage breast cancer patients receiving anthracycline-based chemotherapy in Korea)
  • [SCI] (Combination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive fibromatosis)
  • [SCI] (Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors)
  • [SCI] (Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results)
  • [SCI] (Inflammatory markers as prognostic indicators in pancreatic cancer patients who underwent gemcitabine-based palliative chemotherapy)
  • [SCI] (Incidence and risk factors for congestive heart failure in patients with early breast cancer who received anthracycline and/or trastuzumab: a big data analysis of the Korean Health Insurance Review and Assessment service database)
  • [SCI] (Detection of somatic variants and EGFR mutations in cell-free DNA from non-small cell lung cancer patients by ultra-deep sequencing using the ion ampliseq cancer hotspot panel and droplet digital polymerase chain reaction)
  • [SCI] (Quantification of circulating cell-free DNA to predict patient survival in non-small-cell lung cancer)
  • [SCI] (Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with metastatic pancreatic cancer: a retrospective study)
  • [SCI] (A Selective FGFR inhibitor AZD4547 suppresses RANKL/M-CSF/OPG-dependent osteoclastogenesis and breast cancer growth in the metastatic bone microenvironment)
  • [SCI] (Clinical implications of circulating cell-free DNA quantification and metabolic tumor burden in advanced non-small cell lung cancer)
  • [SCI] (Completion rate of physician orders for life-sustaining treatment for patients with metastatic or recurrent cancer: a preliminary, cross-sectional study)
  • [SCI] (Gemcitabine plus carboplatin versus gemcitabine plus oxaliplatin in cisplatin-unfit patients with advanced urothelial carcinoma: a randomized phase II study (COACH, KCSG GU10-16))
  • [SCI] (Pulmonary function is implicated in the prognosis of metastatic non-small cell lung cancer but not in extended disease small cell lung cancer)

저서

more
  • 유방암 에필로그
  • 두경부암 완전정복
  • 방광암 완전정복
  • 전립선암 완전정복
  • 신장암 완전정복
  • The Essentials of Head & Neck Oncology, Laryngo-Hypopharyngeal Cancer

최종수정일 : 2020.04.08